2 results
Approved WMOCompleted
The objective of this study is to investigate the effect of BWSTT in critically ill patients on time to independent functional ambulation as compared to usual care.
Approved WMORecruiting
The primary objective is to determine if the addition of daratumumab to VRd will prolong PFS defined as the time from the date of randomization to the date of disease progression (assessed by International Myeloma Working Group [IMWG] criteria) or…